Pancreatic Polypeptide
EmergingPancreatic polypeptide supports PPoma diagnosis, typically as part of a broader neuroendocrine tumor marker panel.
Pancreatic polypeptide is a hormone from the pancreas. Very high levels can point to a rare pancreatic tumor, though this test is almost always used alongside other neuroendocrine tumor markers rather than by itself.
Pancreatic polypeptide (PP) is secreted by specialized pancreatic islet cells (PP cells) and helps regulate pancreatic secretion and appetite.
Markedly elevated pancreatic polypeptide supports diagnosis of a PPoma, a rare pancreatic neuroendocrine tumor, and it's sometimes included in broader neuroendocrine tumor marker panels alongside chromogranin A (discussed earlier).
Measured via serum immunoassay, typically as part of a neuroendocrine tumor marker panel rather than in isolation, since it's rarely diagnostic by itself.
Elevated PP in a patient with a pancreatic mass supports pursuing further neuroendocrine tumor workup (imaging, chromogranin A, and other markers) to characterize the tumor before treatment planning.
Rarely diagnostic in isolation; used alongside chromogranin A and other markers for full characterization.
- General endocrine oncology reference literature on pancreatic polypeptide in PPoma and neuroendocrine tumor panels.